ARTICLE | Company News
Ipsen, Dicerna in cancer and endocrine deal
March 31, 2010 1:30 AM UTC
Ipsen Group (Euronext:IPN) and Dicerna Pharmaceuticals Inc. (Watertown, Mass.) partnered to develop conjugates of Dicerna's Dicer Substrate short interfering RNA (DsiRNA) molecules and Ipsen's peptide...